Live Webinar

5 Predictions for Health and Pharma Analytics in 2021

This webinar, part of our Analytics in 20 series, explores trends in operationalizing digital transformation for the health care and life sciences industries.

Jan. 28 • 11 a.m. ET • Cost: Complimentary

About the webinar

For all the challenges presented by the events of 2020, it also forced many organizations to find ways to adapt and thrive.

At every level, from patients to costs to quality to outcomes, analytics became increasingly important to realizing the value of digital transformation.

What comes next is operationalizing it to make the most of what you’ve learned.

In this webinar, we’ll take a broad look at the innovations from the past year that will continue the modernization of health care and life sciences in 2021, with key trends from each industry segment.

Why attend?

  • Hear how life sciences companies are modernizing analytics to change engagement strategies with health care providers and keep clinical trials operating in a decentralized model.
  • Learn why health systems are taking advantage of digital transformation to improve efficiency across clinical and operational decisions, from detecting infection faster to automating claims processing.
  • Discover how health insurers are influencing the entire ecosystem with a 360-degree view, from telehealth to PBM to supply chain.
  • Hear how analytics helps government health agencies meet the needs of vulnerable populations by applying data to understand community needs and optimize resources.
  • Be inspired by the accelerated collaboration across the health and life sciences global ecosystem that’s resulted in new therapies and medical discoveries.

Sie haben bereits ein SAS Profil? Dieses Formular automatisch ausfüllen: Einloggen


Wir behandeln Ihre persönlichen Daten gemäß dem SAS Privacy Statement.

  Ja, ich möchte von SAS Institute Inc. und seinen Tochterunternehmen per E-Mail Informationen zu SAS Produkten, Studien, White Paper und Veranstaltungen erhalten. Mir ist bekannt, dass ich meine Einwilligung jederzeit widerrufen kann, indem ich die Abmeldefunktion in den E-Mails nutze.
Nach dem Absenden dieses Formulars erhalten Sie eine E-Mail, in der wir Sie bitten, Ihre Einwilligung zu bestätigen (Double-Optin-Verfahren). Bitte schauen Sie in Ihrem Posteingang nach einer entsprechenden Nachricht von SAS und klicken den Bestätigungslink. Herzlichen Dank.

About the Experts

Alyssa Farrell, Advisory Industry Marketing Manager, SAS    

Farrell leads industry marketing for the SAS Global Health and Life Sciences Practice. She focuses on the SAS solutions that help optimize health outcomes for individuals and their communities. She is actively engaged in analyst relations, market research and influencer marketing to stay on top of industry trends and align SAS capabilities to customer needs. Previously at SAS, she has supported the energy and public sector global teams. Before joining SAS in 2004, Farrell was a senior consultant in the Deloitte Public Sector Practice.

Mark Lambrecht, Director of the Global Health and Life Sciences Practice, SAS 

Lambrecht joined SAS in 2005 and now leads a senior team working for SAS’ health care and life sciences industry and organizations. For the past few years, he has been focusing on the impact of digital health and “real-world data” in the converging health care ecosystem. He applies SAS high-performance analytics to generate new insights and improve patient outcomes. His team is bringing SAS’ new health care and life sciences solutions to market and is constantly looking for innovation by identifying customer needs. He talks regularly at conferences about analytics and AI in the age of digital health. He is also interested to foster data standards and enable the industry to share and reuse patient data to find new cures and for the benefit of mankind.

Steve Kearney, Medical Director for State and Local Government, SAS

Kearney works with a world-renowned team to help solve the most complex health care challenges using advanced analytical solutions. Prior to joining SAS, he was a Director in the Medical Outcomes Specialists group for Pfizer Global Medical. He worked at Pfizer for 17 years, integrating clinical data into practical protocols. He developed measures and systematic implementations for health outcomes, advising on good health care policy for states. He integrated decision support for delivery networks, evaluated claims for payers and educated them on health outcomes, and provided disease-state insights for providers. Kearney worked every day to improve the lives of patients.